HUP0400940A2 - Injection formulation for treating skin desaeses caused by human papilloma viruses - Google Patents
Injection formulation for treating skin desaeses caused by human papilloma virusesInfo
- Publication number
- HUP0400940A2 HUP0400940A2 HU0400940A HUP0400940A HUP0400940A2 HU P0400940 A2 HUP0400940 A2 HU P0400940A2 HU 0400940 A HU0400940 A HU 0400940A HU P0400940 A HUP0400940 A HU P0400940A HU P0400940 A2 HUP0400940 A2 HU P0400940A2
- Authority
- HU
- Hungary
- Prior art keywords
- desaeses
- caused
- human papilloma
- treating skin
- papilloma viruses
- Prior art date
Links
- 238000002347 injection Methods 0.000 title abstract 2
- 239000007924 injection Substances 0.000 title abstract 2
- 241000701806 Human papillomavirus Species 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 229960001005 tuberculin Drugs 0.000 abstract 1
- 239000012873 virucide Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Abstract
The injection preparation comprises purified freeze-dried tuberculin (1-50 TE/ml) and liquid vehicle, and optionally contains additives. The vehicle is sterilized distilled water, normal saline solution or lidocaine (0.5-1 mass/mass%). ACTIVITY : Dermatological; Virucide. No biological data given. MECHANISM OF ACTION : None given.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400940A HU226845B1 (en) | 2004-05-06 | 2004-05-06 | Process for the preparation of an injection formulation comprising tuberculin as agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400940A HU226845B1 (en) | 2004-05-06 | 2004-05-06 | Process for the preparation of an injection formulation comprising tuberculin as agent |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0400940D0 HU0400940D0 (en) | 2004-08-30 |
HUP0400940A2 true HUP0400940A2 (en) | 2006-08-28 |
HU226845B1 HU226845B1 (en) | 2009-12-28 |
Family
ID=89982200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0400940A HU226845B1 (en) | 2004-05-06 | 2004-05-06 | Process for the preparation of an injection formulation comprising tuberculin as agent |
Country Status (1)
Country | Link |
---|---|
HU (1) | HU226845B1 (en) |
-
2004
- 2004-05-06 HU HU0400940A patent/HU226845B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU226845B1 (en) | 2009-12-28 |
HU0400940D0 (en) | 2004-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814615A (en) | Methods and materials for the treatment and prevention of mucosal tissue inflammation | |
BR0315598A (en) | Neutralizing antibodies to gdf-8 and their uses | |
ES2193777T3 (en) | MICROBIOLOGICALLY STABLE AND INALTERABLE DISSOLUTIONS OF GAMMA-HYDROXIBUTIRATE SALT FOR THE TREATMENT OF NARCOLEPSY. | |
ATE349511T1 (en) | MICROORGANISMS FOR THE TREATMENT OR PREVENTION OF OBESITY AND DIABETES MELLITUS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
BR0001919A (en) | Composition of skin cleansing cream so that it forms foam, and a sparkling skin cleaning system. | |
BR0103256A (en) | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body | |
SE9502167D0 (en) | Insulin analog formulations | |
WO2003075850A3 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
SG45225A1 (en) | A novel physiologically active substance | |
WO2006114105A8 (en) | Use of modified factor vii for treating bleeding | |
FR2865651B1 (en) | TOPICAL COMPOSITIONS COMPRISING SODIUM HYALURONATE FRAGMENTS AND RETINOID USEFUL IN COSMETIC AND MEDICAL DERMATOLOGY | |
BRPI9910024B8 (en) | use of a mixture of sugar alcohols containing 6-o-alpha-d-glycopyranosyl-d-sorbitol (1,6-gps) and 1-o-alpha-d-glycopyranosyl-d-mannitol (1,1-gpm) in vitro, and pharmaceutical composition for human or animal consumption | |
SE0102147D0 (en) | New methods | |
BR0314533A (en) | System for supplying useful substance to human body in a sauna space | |
EP2261260A3 (en) | Methods for inducing autolysis in infectious bacteria | |
CN102988962B (en) | A kind of complex for preventing or treat skin pruritus | |
HUP0400940A2 (en) | Injection formulation for treating skin desaeses caused by human papilloma viruses | |
BR0017340A (en) | Treatment of trauma and other indications | |
Sada et al. | Necrotizing fasciitis and myonecrosis “synergistic necrotizing cellulitis” caused by Bacillus cereus | |
RU2006109966A (en) | YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES | |
DE60209355D1 (en) | COSMETIC PREPARATION AGAINST HAINFALTEN | |
NO20034453L (en) | Use of CD25-binding molecules in steroid-resistant patients | |
JP2006199620A (en) | Cosmetic obtained by applying silicon compound and its manufacturing method | |
Juzans et al. | Enhancement of quantal acetylcholine release and selective depletion of clear synaptic vesicules from motor nerve terminals poisoned with a peptide isolated from the venom of the stone fish (Synanceia trachynis) | |
ATE496628T1 (en) | USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |